Insider Cluster (2 insiders) ·Filed Aug 10, 2026

IMNM

Immunome Inc.
NEUTRAL
Impact 3/10
Horizondays Processed1mo ago
Insider cluster: 2 insiders, $2.8M total
Actionable Insight • Neutral

Insider sales are small relative to market cap and likely routine post-exercise liquidity. No bearish signal from this cluster alone. Monitor for any upcoming news (e.g., trial data, partnership) that could explain timing, but the dollar amount does not warrant a directional trade.

DirectionNeutral
Confidencemedium
Horizondays
Latest settled — T+20d
IMNM ▼ -0.50% at T+20d
NEUTRAL call ✗ call lost -0.50% · α vs SPY +0.56% · entry $26.25 → $26.12
Next anchor: T+60d in 5w
Latest observation: T+34 -13.50% FF3 residual α
Entry anchored
Aug 10, 04:00 PM ET
via 1-min bar
T+1d
+6.63%
call +6.63% · α +6.38%
$27.99
settled 7w ago
T+5d
+4.99%
call +4.99% · α +5.39%
$27.56
settled 7w ago
T+20d
-0.50%
call -0.50% · α +0.56%
$26.12
settled 24d ago
T+60d
—
call — · α —
—
in 5w

Price Chart

Loading chart...

Executive Summary

Two insiders at Immunome (IMNM) sold a total of ~$2.82M in shares over a 7-day window. The CBO sold $2.27M after exercising options, and a director sold $543K. Relative to IMNM's $2.8B market cap, these sales are ~0.1% and are routine in size, likely driven by option exercise and diversification rather than a negative signal.

Key Financial Metrics

Direction
selling
Total Value
$2.8M
Insiders
2

Key Facts

  • CBO Horn Kinney sold 90,616 shares at $25.09 for $2.27M on Aug 4, following derivative exercises at lower strike prices.
  • Director Barchas Isaac sold 20,840 shares at $26.06 for $543K on Aug 6.
  • Total open-market sales represent ~$2.82M, or ~0.1% of IMNM's $2.8B market cap.
  • No other contextual filings (earnings, press releases, restatements) accompany this cluster.

Financial Impact

Sales of ~$2.82M, ~0.1% of market cap — immaterial

insider selling

Risk Factors

  • Market may misinterpret cluster selling as negative, but the size is too small to move the stock.
  • CBO sold a sizable portion of exercised options, which could signal mild caution if repeated at higher volumes.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-IMNM-1786392651778
13 reports for IMNM
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+60▲ +26.53%May 28, 2026
Filters
Rows
Reports for IMNM — sortable, filterable
TypeNow
Oct 1, 2026
1d ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$21.58 awaiting T+5awaiting T+5—$20.97 (−2.85%)
Sep 21, 2026
11d ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$25.07 $21.68▼ −13.52%▼ −13.24%$20.97 (−16.37%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$26.42 $28.08▲ +6.28%▲ +8.25%$20.97 (−20.65%)
Aug 10, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$26.25 $27.56▲ +4.99%▲ +5.39%$20.97 (−20.13%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 4/10
$23.35 $22.20▼ −4.93%▼ −4.36%$20.97 (−10.21%)
Jul 7, 2026
12w ago
Insider Cluster
NEUTRAL ★ 4/10
$24.01 $22.59▼ −5.91%▼ −6.78%$20.97 (−12.68%)
Jul 7, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.01 $22.59▼ −5.91%▼ −6.78%$20.97 (−12.68%)
Jul 3, 2026
13w ago
Insider Cluster
BEARISH ★ 5/10
$23.61 $24.17▼ −2.37%▼ −1.44%$20.97 (+11.20%)
May 28, 2026
18w ago
ANALYST-UPGRADE
BULLISH ★ 3/10
$22.54 $19.81▼ −12.11%▼ −12.06%$20.97 (−6.99%)
May 12, 2026
20w ago
8-K
BULLISH ★ 7/10
$22.20 $19.66▼ −11.44%▼ −10.28%$20.97 (−5.56%)
Showing 10 of 13

US Market Status

Market Open — Closes in 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 10, 2026